FV
Flagship Ventures 2007 General Partner LLC
13F filer · CIK 0001508053Last filed Aug 15, 2016
Inactive · not filing 13F
13F portfolio value$107MU.S. long equity reported on 13F
Positions4Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight100.0%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2016Reported Aug 15, 20164 positions | |||||
| $80.9M | 75.24% | 5.08% | Not reported | Q4 2013 | |
| $23.1M | 21.50% | 9.23% | New | Q2 2016 | |
| CTEBIOCarisma Therapeutics Inc. | $3.2M | 2.98% | Not reported | Not reported | Q1 2014 |
| REREGIRenewable Energy Group, Inc. | $296K | 0.28% | Not reported | Not reported | Q2 2014 |
| Q4 2015Reported Feb 12, 20164 positions | |||||
| $125M | 82.23% | 5.12% | Not reported | Q4 2013 | |
| $21M | 13.80% | 1.53% | Not reported | Q2 2015 | |
| CTEBIOCarisma Therapeutics Inc. | $5.74M | 3.77% | Not reported | Not reported | Q1 2014 |
| REREGIRenewable Energy Group, Inc. | $312K | 0.20% | Not reported | +3.8% | Q2 2014 |
| Q3 2015Reported Nov 13, 20155 positions | |||||
| $136M | 85.66% | 5.13% | Not reported | Q4 2013 | |
| $17.8M | 11.17% | 1.53% | Not reported | Q2 2015 | |
| CTEBIOCarisma Therapeutics Inc. | $4.6M | 2.89% | Not reported | Not reported | Q1 2014 |
| REREGIRenewable Energy Group, Inc. | $268K | 0.17% | Not reported | -7.5% | Q2 2014 |
| BMBGMDBG Medicine, Inc. | $181K | 0.11% | 3.96% | 0.0% | Q4 2013 |
| Q2 2015Reported Jul 28, 20155 positions | |||||
| $215M | 87.15% | 5.16% | Not reported | Q4 2013 | |
| $24.9M | 10.10% | 1.97% | New | Q2 2015 | |
| CTEBIOCarisma Therapeutics Inc. | $5.38M | 2.18% | Not reported | Not reported | Q1 2014 |
| BMBGMDBG Medicine, Inc. | $970K | 0.39% | 20.36% | Not reported | Q4 2013 |
| REREGIRenewable Energy Group, Inc. | $404K | 0.16% | Not reported | -62.9% | Q2 2014 |
Premium opens every quarter this fund has filed